Video

Combining Local and Systemic Therapies in Liver Cancer

Author(s):

Ghassan K. Abou-Alfa, M.D.

Can local and systemic therapies be combined to treat liver cancer?

Ghassan K. Abou-Alfa, M.D., medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the future of combining local and systemic therapy to treat liver cancer.

Currently, there is a divide between local (delivered directly to the tumor) therapy and systemic (given throughout the whole body) therapy in the treatment of liver cancer. However, Abou-Alfa said, "This is about marriage, not divorce," between the two treatment methods, and expects combination regimens to emerge on the scene.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of kelly.
Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.
Image of Doctor.
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Image of Dr. Doug
Image of doctor.
Image of Dr. Kelly
Image of Dr. Boffa.
Immune Therapy Expands Melanoma Treatment to More Patients
Related Content
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
Marshall Morris, the founder of Dying Defiantly
December 8th 2022

Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story

Sailaja Darisipudi Andy Polhamus
After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
Making Art From Cancer
December 10th 2020

Making Art From Cancer

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with renowned street artist James Cochran about one of his art projects that was commissioned to symbolize the creativity and commitment of those who work tirelessly to eradicate cancer.
Illustration of liver.
March 10th 2025

Lenvima Plus Keytruda With TACE May Improve Liver Cancer Outcomes

Alex Biese
For patients with unresectable, non-metastatic hepatocellular carcinoma, Lenvima plus Keytruda in combination with TACE improved outcomes.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.